1
|
Zheng XY, Feng GW, Guo J, Xie F, Li X, Zhang MZ, Zhang XF, Wu XF, Ding YJ. A cross-sectional study of appropriateness evaluation of anticoagulation therapy for inpatients with nonvalvular atrial fibrillation. Front Pharmacol 2023; 14:1286559. [PMID: 38116077 PMCID: PMC10728771 DOI: 10.3389/fphar.2023.1286559] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2023] [Accepted: 11/21/2023] [Indexed: 12/21/2023] Open
Abstract
Background: Oral anticoagulants (OACs) are essential for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF). However, the appropriateness of anticoagulation treatment in locally practice remains unclear. This study evaluated compliance with anticoagulation therapy concerning the guidelines and drug labels in patients with NVAF. Methods: Hospitalized patients diagnosed with NVAF between 1 November 2020, and 31 December 2021, were retrospectively enrolled. The appropriateness of anticoagulation regimens at discharge was evaluated based on a flowchart designed according to atrial fibrillation (AF) guidelines and medication labels. Furthermore, we explored factors potentially influencing the "no-use of OACs" using binary logistic regression and verified anticoagulation-related issues through a physician questionnaire. Results: A total of 536 patients were enrolled in this study, including 254 patients (47.4%) with inappropriate anticoagulation regimens. 112 patients (20.9%) were categorized as "underdosing-use of OACs," 134 (25%) who needed anticoagulation therapy were "no-use of OACs" and eight (1.5%) were "over-use of OACs." The results of a binary logistic regression analysis showed that paroxysmal AF (odds ratio [OR], 7.74; 95% confidence interval [CI], 4.57-13.10), increased blood creatinine levels (OR, 1.88; 95% CI, 1.11-3.16), hospitalized pacemaker implantation (OR, 6.76; 95% CI, 2.67-17.11), percutaneous coronary intervention (OR, 3.35; 95% CI, 1.44-7.80), and an increased HAS-BLED score (OR, 1.62; 95% CI, 1.11-2.35) were associated with "no-use of OACs" in patients with NVAF who had indications for anticoagulation therapy. Conclusion: For patients with NVAF with severe renal dysfunction and paroxysmal AF, anticoagulation therapy was inadequate. The underdosing-use of OACs in patients with NVAF was frequently observed. We recommend an anticoagulation management team to tailor anticoagulation regimens to suit each patient's needs.
Collapse
Affiliation(s)
- Xiao-Yuan Zheng
- Department of Pharmacy, Affiliated Hospital of Jiangnan University, Wuxi, China
| | - Guang-Wei Feng
- Department of Pharmacy, Dahua Hospital, Xuhui District, Shanghai, China
| | - Jing Guo
- Department of Cardiology, Affiliated Hospital of Jiangnan University, Wuxi, China
| | - Fen Xie
- Department of Pharmacy, Affiliated Hospital of Jiangnan University, Wuxi, China
| | - Xia Li
- Department of Pharmacy, Affiliated Hospital of Jiangnan University, Wuxi, China
| | - Ming-Zhu Zhang
- Department of Pharmacy, Shandong Provincial Third Hospital, Jinan, China
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China
| | - Xiu-Fen Zhang
- Oncology Institute, Affiliated Hospital of Jiangnan University, Wuxi, China
| | - Xiu-Feng Wu
- Department of Pharmacy, Affiliated Hospital of Jiangnan University, Wuxi, China
| | - Yong-Juan Ding
- Department of Pharmacy, Affiliated Hospital of Jiangnan University, Wuxi, China
| |
Collapse
|
2
|
Feng GW, Wang ZF, He P, Lan QY, Ni L, Yang YZ, Wang CF, Cui TT, Huang LL, Yan YQ, Jiang ZW, Yang Q, Yu BW, Han X, Chen JJ, Yang SY, Yuan L, Zhou LY, Liu G, Li K, Huang Z, Zhao JC, Hu ZY, Xie ZQ. Safety, tolerability, and immunogenicity of a CpG/Alum adjuvanted SARS-CoV-2 recombinant protein vaccine (ZR202-CoV) in healthy adults: Preliminary report of a phase 1, randomized, double-blind, placebo-controlled, dose-escalation trial. Hum Vaccin Immunother 2023; 19:2262635. [PMID: 37881130 PMCID: PMC10644802 DOI: 10.1080/21645515.2023.2262635] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2023] [Accepted: 09/20/2023] [Indexed: 10/27/2023] Open
Abstract
This was a phase 1 dose-escalation study of ZR202-CoV, a recombinant protein vaccine candidate containing a pre-fusion format of the spike (S)-protein (S-trimer) combined with the dual-adjuvant system of Alum/CpG. A total of 230 participants were screened and 72 healthy adults aged 18-59 years were enrolled and randomized to receive two doses at a 28-day interval of three different ZR202-CoV formulations or normal saline. We assessed the safety for 28 days after each vaccination and collected blood samples for immunogenicity evaluation. All formulations of ZR202-CoV were well-tolerated, with no observed solicited adverse events ≥ Grade 3 within 7 days after vaccination. No unsolicited adverse events ≥ Grade 3, or serious adverse events related to vaccination occurred as determined by the investigator. After the first dose, detectable immune responses were observed in all subjects. All subjects that received ZR202-CoV seroconverted at 14 days after the second dose by S-binding IgG antibody, pseudovirus and live-virus based neutralizing antibody assays. S-binding response (GMCs: 2708.7 ~ 4050.0 BAU/mL) and neutralizing activity by pseudovirus (GMCs: 363.1 ~ 627.0 IU/mL) and live virus SARS-CoV-2 (GMT: 101.7 ~ 175.0) peaked at 14 days after the second dose of ZR202-CoV. The magnitudes of immune responses compared favorably with COVID-19 vaccines with reported protective efficacy.
Collapse
Affiliation(s)
- Guang-Wei Feng
- Vaccine Clinical Research Center, Henan Provincial Center for Disease Control and Prevention, Zhenzhou, HA, China
| | - Zhong-Fang Wang
- State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, GD, China
- Division of Drug and Vaccine Research, Guangzhou Laboratory, Bioland, Guangzhou, GD, China
| | - Peng He
- Department of Hepatitis and Enterovirus Vaccine, National Institutes for Food and Drug Control, Beijing, China
| | - Qin-Ying Lan
- R&D Department, Shanghai Zerun Biotechnology Co. Ltd, Shanghai, China
| | - Ling Ni
- School of Medicine, Tsinghua University, Beijing, China
| | - Ya-Zheng Yang
- School of Medicine, Tsinghua University, Beijing, China
| | - Chen-Fei Wang
- Department of Hepatitis and Enterovirus Vaccine, National Institutes for Food and Drug Control, Beijing, China
| | - Ting-Ting Cui
- State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, GD, China
| | - Li-Li Huang
- Vaccine Clinical Research Center, Henan Provincial Center for Disease Control and Prevention, Zhenzhou, HA, China
| | - Yong-Qiang Yan
- Vaccine Program Office, Xiangcheng County Center for Disease Control and Prevention, Xiangcheng, HA, China
| | - Zhi-Wei Jiang
- Statistics and Decision Sicence, Beijing Key Tech Statistical Consulting Co. Ltd, Beijing, China
| | - Qing Yang
- R&D Department, Shanghai Zerun Biotechnology Co. Ltd, Shanghai, China
| | - Bang-Wei Yu
- R&D Department, Shanghai Zerun Biotechnology Co. Ltd, Shanghai, China
| | - Xi Han
- R&D Department, Shanghai Zerun Biotechnology Co. Ltd, Shanghai, China
| | - Jing-Jing Chen
- R&D Department, Walvax Biotechnology Co. Ltd, Kunming, Yunnan, China
| | - Shu-Yuan Yang
- R&D Department, Walvax Biotechnology Co. Ltd, Kunming, Yunnan, China
| | - Lin Yuan
- R&D Department, Walvax Biotechnology Co. Ltd, Kunming, Yunnan, China
| | - Ling-Yun Zhou
- R&D Department, Shanghai Zerun Biotechnology Co. Ltd, Shanghai, China
| | - Ge Liu
- R&D Department, Shanghai Zerun Biotechnology Co. Ltd, Shanghai, China
| | - Ke Li
- R&D Department, Shanghai Zerun Biotechnology Co. Ltd, Shanghai, China
| | - Zhen Huang
- R&D Department, Walvax Biotechnology Co. Ltd, Kunming, Yunnan, China
| | - Jin-Cun Zhao
- State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, GD, China
- Division of Drug and Vaccine Research, Guangzhou Laboratory, Bioland, Guangzhou, GD, China
| | - Zhong-Yu Hu
- Department of Hepatitis and Enterovirus Vaccine, National Institutes for Food and Drug Control, Beijing, China
| | - Zhi-Qiang Xie
- Vaccine Clinical Research Center, Henan Provincial Center for Disease Control and Prevention, Zhenzhou, HA, China
| |
Collapse
|
3
|
Yan YC, Wang ZG, Qi YB, Feng Y, Feng YH, Jia YL, Cheng FM, Feng GW, Jiang W, Shang WW. [Factors affecting BK polyomavirus infection after kidney transplantation in post-school children and a predictive infection model]. Zhonghua Yi Xue Za Zhi 2023; 103:1538-1545. [PMID: 37246003 DOI: 10.3760/cma.j.cn112137-20230105-00021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
Objective: To analyze high-risk factors affecting BK polyomavirus (BKPyV) infection and to construct a prediction model for BKPyV infection in children after renal transplantation. Methods: The clinical data of 332 children who received allogeneic kidney transplantation in the First Affiliated Hospital of Zhengzhou University from January 2014 to March 2022 were retrospectively collected. According to the BKPyV load level, the dynamic change process of lymphocytes at different time points were analyzed. The factors that have potential influence on BKPyV infection were screened by Cox regression analysis, and the receiver operating characteristic curve (ROC) was used to evaluate the sensitivity and specificity of the predictive model of infection. Results: Among the 332 children, there were 215 males and 117 females; the age of transplantation was (12.2±3.9) years old; 37 cases were preschool (1-5 years old), and 295 cases were post-school age (6-18 years old). BKPyV load in 224 urine samples and 30 blood samples of children were detected. There were 9 cases of BKPyV-associated viruria and 3 cases of BKPyV associated viremia in pre-school children, 76 cases BKPyV associated viruria and 14 cases of BKPyV associated viremia in post-school children. Multivariate Cox regression analysis showed that higher body mass index (BMI) (HR=1.105, 95%CI: 1.020-1.197), antithyroglobulin (ATG) application (HR=2.196, 95%CI: 1.335-3.613), and higher tacrolimus concentration (HR=2.484, 95%CI: 1.298-4.753), higher natural killer (NK) lymphocyte count (HR=1.193, 95%CI: 1.009-1.411), higher CD14++CD16-cell count (HR=1.096, 95%CI: 1.024-1.173) were independent risk factors for BKPyV associated viruria in post-school children. Delayed graft function (DGF) (HR=4.993, 95%CI: 1.555-16.038), Acute rejection (AR) (HR=6.021, 95%CI: 1.930-18.787), higher CD14++CD16-cell count (HR=1.227, 95%CI: 1.081-1.392) were independent risk factors for BKPyV associated viremia in post-school children. The results of ROC curve analysis showed that combined BMI, immune induction drugs, tacrolimus concentration, NK cell count, and CD14++CD16-cell count predicted the occurrence of BKPyV associated viruria in post-school children after kidney transplantation at 0.5, 1, 2, and 5 years with area under curve (AUC) of 0.712 (95%CI: 0.626-0.798), 0.708 (95%CI: 0.612-0.804), 0.754 (95%CI: 0.668-0.840) and 0.767 (95%CI: 0.685-0.849). The sensitivity and specificity of the model were 64.9%, 61.4%, 61.6%, 55.8% and 70.9%, 72.4%, 76.0%, 84.0%, respectively. Combined with DGF, AR, and CD14++CD16-cell counts predicted the occurrence of BKPyV-associated viremia at 0.5, 1, 2, and 5 years after renal transplantation in post-school children with AUC of 0.791 (95%CI: 0.631-0.951), 0.744 (95%CI: 0.547-0.936), 0.786 (95%CI: 0.629-0.946) and 0.812 (95%CI: 0.672-0.948). The sensitivity and specificity of the model were 76.1%, 67.1%, 75.0%, 77.9% and 88.9%, 89.0%, 89.9%, 88.0%, respectively. Conclusions: The postoperative CD14++CD16-cell level can be used as an independent predictor of BKPyV infection in post-school children after renal transplantation. Combined BMI, immune induction drugs, tacrolimus concentration, NK cell count, CD14++CD16-cell count and combined DGF, AR, CD14++CD16-cell count show good fitting effect in predicting the occurrence of BKPyV-associated viruria and viremia after transplantation in post-school children respectively.
Collapse
Affiliation(s)
- Y C Yan
- Department of Renal Transplantation, First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou 450052, China
| | - Z G Wang
- Department of Renal Transplantation, First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou 450052, China
| | - Y B Qi
- Department of Renal Transplantation, First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou 450052, China
| | - Y Feng
- Department of Renal Transplantation, First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou 450052, China
| | - Y H Feng
- Department of Renal Transplantation, First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou 450052, China
| | - Y L Jia
- BGI College & Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450052, China
| | - F M Cheng
- Department of Renal Transplantation, First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou 450052, China
| | - G W Feng
- Department of Renal Transplantation, First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou 450052, China
| | - W Jiang
- Academy of Medical Sciences, Zhengzhou University, Zhengzhou 450052, China
| | - W W Shang
- Department of Renal Transplantation, First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou 450052, China
| |
Collapse
|
4
|
Huang LL, Ma XM, Huang HT, Xie ZQ, Gou JB, Yang YL, Wang X, Zhang W, You WY, Tan JB, Xu LF, Feng GW, Zhu T, Wang Y. [Immunogenicity of group A+C meningococcal polysaccharide conjugate vaccine in infants: A phase Ⅲ clinical trial study]. Zhonghua Yu Fang Yi Xue Za Zhi 2022; 56:1728-1733. [PMID: 36536558 DOI: 10.3760/cma.j.cn112150-20211206-01124] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/17/2023]
Abstract
Objective: To evaluate the immunogenicity of group A+C meningococcal polysaccharide conjugate vaccine in infants under 2 years old. Methods: From March 2017 to June 2018, 1 932 healthy infants in Biyang County, Henan Province, who were not vaccinated with meningococcal meningitis vaccine and whose axillary temperature was ≤37.0 ℃, were recruited as participants. The 3 months and 6-11 months old infants were allocated to the experiment group and the control group in a ratio of 1∶1. Infants aged 12-23 months were allocated to the 1-dose group, the 2-dose group and the control group in a ratio of 1∶1∶1, with 276 infants in each group. The infants in the experiment group were intramuscularly injected with freeze-dried group A+C meningococcal polysaccharide conjugate vaccine to be evaluated, and infants in the control group received intramuscular injection of commercially available freeze-dried group A+C meningococcal conjugate vaccine. The venous blood of infants was collected 30 days before the first dose and after the last dose of inoculation, and the antibody seroconversion of each group was determined and compared. Results: The completion rate of immunogenicity study was 95.2% (1 839/1 932). Before inoculation, there was no statistical difference in the geometric mean titer and positive rate of group A+C antibodies between the experiment group and the control group in 3 months and 6-11 months old infants (all P values >0.05). The geometric mean titers and positive rate of group A antibodies in the 1-dose group were higher than those in the control group (all P values <0.05), but there was no statistical difference between the 2-dose group and the control group (all P values >0.05) in infants aged 12-23 months. After inoculation, the differences (95%CI) in the positive conversion rate of group A+C antibodies between the experiment group and the control group were -0.12% (-6.01%-5.77%) and 0.82% (-4.23%-5.86%) in the 3 months old infants. At the age of 6-11 months, the differences were 6.75% (1.71%-11.79%) and -4.32% (-8.73%-0.08%), respectively. At the age of 12-23 months, the differences were 1.02% (-3.80%-5.83%) and -4.40% (-7.79%- -1.01%) in the 2-dose group and -7.22% (-12.90%- -1.54%) and -18.61% (-23.75%- -13.46%) in the 1-dose group, respectively. The geometric mean titers of group A+C antibodies in the 3 months old infants were 48.50 and 63.12, respectively, which had no significant difference from the control group (43.02 and 57.99, respectively) (both P values <0.05). The geometric mean titers of group A+C antibodies in the 6-11 months and 12-23 months old infants were 84.09 and 92.51 (2-dose group), which were higher than those in the corresponding control group (43.10 and 61.83, respectively) (all P values <0.001). Conclusion: Group A+C meningococcal conjugate vaccine has good immunogenicity in infants under 2 years old.
Collapse
Affiliation(s)
- L L Huang
- Center of Vaccine Clinical Trial, Henan Center for Disease Control and Prevention, Zhengzhou 450016, China
| | - X M Ma
- CanSino Biologics Inc., Tianjin 300457, China
| | - H T Huang
- CanSino Biologics Inc., Tianjin 300457, China
| | - Z Q Xie
- Center of Vaccine Clinical Trial, Henan Center for Disease Control and Prevention, Zhengzhou 450016, China
| | - J B Gou
- CanSino Biologics Inc., Tianjin 300457, China
| | - Y L Yang
- Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou 450001, China
| | - X Wang
- CanSino Biologics Inc., Tianjin 300457, China
| | - W Zhang
- Center of Vaccine Clinical Trial, Henan Center for Disease Control and Prevention, Zhengzhou 450016, China
| | - W Y You
- Center of Vaccine Clinical Trial, Henan Center for Disease Control and Prevention, Zhengzhou 450016, China
| | - J B Tan
- Center of Vaccine Clinical Trial, Henan Center for Disease Control and Prevention, Zhengzhou 450016, China
| | - L F Xu
- CanSino Biologics Inc., Tianjin 300457, China
| | - G W Feng
- Center of Vaccine Clinical Trial, Henan Center for Disease Control and Prevention, Zhengzhou 450016, China
| | - T Zhu
- CanSino Biologics Inc., Tianjin 300457, China
| | - Yanxia Wang
- Center of Vaccine Clinical Trial, Henan Center for Disease Control and Prevention, Zhengzhou 450016, China
| |
Collapse
|
5
|
Zhu KL, Feng YH, Hu MY, Cui KX, Shang WW, Liu L, Wang JX, Wang ZG, Zhang LY, Cheng FM, Zhang J, Wang ZQ, Feng GW. [Analysis of prognostic factors of pediatric kidney transplantation]. Zhonghua Er Ke Za Zhi 2022; 60:888-893. [PMID: 36038297 DOI: 10.3760/cma.j.cn112140-20220330-00257] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Objective: To evaluate the short-and mid-term efficacy of pediatric kidney transplantation and the risk factors for kidney graft and recipient. Methods: The baseline data and postoperative complications of pediatric donors and recipients of 284 kidney transplants were retrospectively analyzed in the Department of Kidney Transplantation in the First Affiliated Hospital of Zhengzhou University from August 2010 to May 2021 and all subjects were followed up until December 31, 2021. According to the survival status of donors and recipients, they were divided into the graft-loss group and the graft-survival group, and the recipient death group and survival group, respectively. Univariate comparison between groups was performed by Log-rank test, and Cox proportional risk model was used to explore the independent risk factors for the graft and recipient survival. Results: Among the 284 children recipients, 184 cases (64.8%) were male and 100 cases(35.2%) were female, and 19 cases (6.7%) were living relative donor renal transplantation, 19 cases (6.7%) were preemptive transplantation, and 8 cases were secondary transplantation. The age of 284 recipients at the time of transplantation was 13.0 (9.0, 15.0) years, among whom 29 cases aged 0-6 years, 96 cases aged 7-11 years old, and 159 cases aged 12-18 years. The 1, 3, and 5 year survival rates were 92.3%, 88.9% and 84.8% for the kidney grafts, and were 97.1%, 95.6% and 94.4% for the recipients, respectively. Multivariate analysis showed postoperative acute rejection (HR=3.14, 95%CI 1.38-7.15, P=0.006) and perioperative vascular complications (HR=4.73, 95%CI 2.03-11.06, P<0.001) were independent risk factors for the survival of kidney graft. Postoperative infection (HR=14.23, 95%CI 3.45-58.72, P<0.001) was an independent risk factor for the postoperative mortality of recipients. Conclusions: Pediatric kidney transplantation shows a good short-and mid-term prognosis. Postoperative acute rejection and perioperative vascular complications are the risk factors for the survival of kidney graft, and postoperative infection is the risk factor affecting the survival of recipient.
Collapse
Affiliation(s)
- K L Zhu
- Department of Kidney Transplantation, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China
| | - Y H Feng
- Department of Kidney Transplantation, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China
| | - M Y Hu
- Department of Kidney Transplantation, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China
| | - K X Cui
- Department of Kidney Transplantation, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China
| | - W W Shang
- Department of Kidney Transplantation, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China
| | - L Liu
- Department of Kidney Transplantation, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China
| | - J X Wang
- Department of Kidney Transplantation, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China
| | - Z G Wang
- Department of Kidney Transplantation, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China
| | - L Y Zhang
- Department of Kidney Transplantation, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China
| | - F M Cheng
- Department of Kidney Transplantation, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China
| | - J Zhang
- Department of Kidney Transplantation, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China
| | - Z Q Wang
- Department of Kidney Transplantation, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China
| | - G W Feng
- Department of Kidney Transplantation, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China
| |
Collapse
|
6
|
Sun RC, Lyu KY, Feng GW, Xu QY, Lan YJ. [The mediating role of worker-occupation fit between occupational stress and anxiety symptoms in medical staff]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2022; 40:495-500. [PMID: 35915938 DOI: 10.3760/cma.j.cn121094-20210425-00231] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Objective: To analyze the mediating effect of work-occupation fit between occupational stress and anxiety symptoms in medical staff. Methods: Convenience sampling method was adopted to select participants of one general hospital and three specialized hospitals as respondents for a questionnaire survey in Henan Province from October 2020 to January 2021. A total of 2050 medical staff were investigated, and 1988 valid questionnaires were collected, and the effective rate of the questionnaire was 97.0% (1988/2050) . The "Depression-Anxiety-Stress Scale" and "Worker-Occupation Fit Inventory" were used to evaluate the occupational stress, anxiety symptoms and worker-occupation fit level of medical staff, and the mediation effect of work-occupation fit on the relationship between occupational stress and anxiety symptoms was analyzed using a mediating effect model. Results: The average age of the 1988 medical staff was (32.7±7.8) years old, the positive detection rates of occupational stress and anxiety symptoms were 42.5% (845/1988) and 56.7% (1127/1988) , respectively. Anxiety symptoms of medical staff were positively correlated with occupational stress, negatively correlated with worker-occupation fit (r=0.831, -0.364, P<0.001) , work-occupation fit was negatively correlated with occupational stress (r=-0.259, P<0.001) . The results of the mediation effect analysis showed that occupational stress had a direct effect on anxiety symptoms (β=0.677, BCa 95%CI: 0.648-0.707) , and worker-occupation fit (β=0.047, BCa 95%CI: 0.039-0.056) , characteristic fit (β=0.089, BCa 95%CI: 0.074-0.104) , need-supply fit (β=0.075, BCa 95%CI: 0.062-0.089) , and ability-demand fit (β=0.035, BCa 95%CI: 0.026-0.044) mediated the association between occupational stress and anxiety symptoms in medical staff, with the mediating effect as a percentage of 6.5%, 12.3%, 10.3%, and 4.8%, respectively. Conclusion: Worker-occupation fit has a mediating effect between occupational stress and anxiety symptoms in medical staff, but mainly direct effect.
Collapse
Affiliation(s)
- R C Sun
- Department of Preventive Medicine, School of Public Health, Chengdu Medical College, Chengdu 610500, China
| | - K Y Lyu
- Department of Occupational and Environmental Health, West China School of Public Health/West China Fourth Hospital, Sichuan University, Chengdu 610041, China
| | - G W Feng
- Department of Occupational and Environmental Health, West China School of Public Health/West China Fourth Hospital, Sichuan University, Chengdu 610041, China
| | - Q Y Xu
- Department of Occupational and Environmental Health, West China School of Public Health/West China Fourth Hospital, Sichuan University, Chengdu 610041, China
| | - Y J Lan
- Department of Occupational and Environmental Health, West China School of Public Health/West China Fourth Hospital, Sichuan University, Chengdu 610041, China
| |
Collapse
|
7
|
Feng GW, Sun RC, Xu QY, Lan YJ. [Literature analysis of hot topics on occupational noise-induced hearing loss]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2022; 40:279-282. [PMID: 35545595 DOI: 10.3760/cma.j.cn121094-20210329-00174] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Objective: To analyze the literature of related research reports on occupational hearing loss (ONIHL) , study the characteristics of the subject and determine the research hotspots. Methods: In December 2020, PubMed database was searched by bibliometrics for ONIHL published in PubMed database from January 1971 to December 2020. Bicomb 2.03 software was used to extract the subject. The publication year, publication country, source magazine and subject words were summarized and analyzed. Results: A total of 1 473 papers were included in this study, and the number of papers was 66 from 1971 to 1980, and 628 from 2011 to 2020, an increase of nearly 10 times. The top three countries were the United States, China and Germany, with 31.5% (464/1473) , 11.5% (171/1473) and 6.2% (91/1473) ; The cross-sectional study was the most applied type; The top five words for 2011-2020: Mental Illness, polymorphism, cardiovascular disease, high frequency hearing impairment and standards and regulations. Conclusion: Susceptibility Genes, Psychological Disorders, Cardiovascular Diseases and Risk Assessment are hot areas in ONIHL at present. Researchers should focus on major fields and grasp future trends as a whole.
Collapse
Affiliation(s)
- G W Feng
- West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu 610041, China
| | - R C Sun
- Department of Preventive Medicine, School of Public Health, Chengdu Medical College, Chengdu 610050, China
| | - Q Y Xu
- West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu 610041, China
| | - Y J Lan
- West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu 610041, China
| |
Collapse
|
8
|
Feng GW, Liu X, Qi Q, Wang SJ, Yang CT, Zuo M, Zhang GZ. Skin Ultrastructure and the Changes of HIF-2α, H-FABP Expression in the Myocardium of Electric Shock Death Rats. Fa Yi Xue Za Zhi 2021; 37:158-165. [PMID: 34142475 DOI: 10.12116/j.issn.1004-5619.2020.400321] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 03/19/2020] [Indexed: 11/30/2022]
Abstract
Abstract Objective To observe the skin ultrastructure change of electric shock death rats and to test the expression changes of hypoxia-inducible factor-2α (HIF-2α) and heart type-fatty acid-binding protein (H-FABP) of myocardial cells, in order to provide basis for forensic identification of electric shock death. Methods The electric shock model of rats was established. The 72 rats were randomly divided into control group, electric shock death group and postmortem electric shock group. Each group was divided into three subgroups, immediate (0 min), 30 min and 60 min after death. The skin changes of rats were observed by HE staining, the changes of skin ultrastructure were observed by scanning electron microscopy, and the expression of HIF-2α and H-FABP in rats myocardium was tested by immunohistochemical staining. Results The skin in the electric shock death group and postmortem electric shock group had no significant difference through the naked eye or by HE staining. Under the scanning electron microscope, a large number of cellular debris, cells with unclear boundaries, withered cracks, circular or elliptical holes scattered on the cell surface and irregular edges were observed. A large number of spherical foreign body particles were observed. Compared with the control group, the expression of HIF-2α in all electric shock death subgroups increased, reaching the peak immediately after death. In the postmortem electric shock group, HIF-2α expression only increased immediately after death, but was lower than that of electric shock death group (P<0.05). Compared with the control group, the expression of H-FABP in all subgroups of electric shock death group and postmortem electric shock group significantly decreased. The expression of H-FABP in all subgroups of electric shock death group was lower than that of the postmortem electric shock group (P<0.05). Conclusion Electric shock can increase HIF-2α expression and decrease H-FABP expression in the myocardium, which may be of forensic significance for the determination of electric shock death and identification of antemortem and postmortem electric shock.
Collapse
Affiliation(s)
- G W Feng
- Judicial Expertise Center, the First Hospital of Hebei Medical University, Shijiazhuang 050031, China
| | - X Liu
- Hebei Key Laboratory of Forensic Medicine, College of Forensic Medicine, Hebei Medical University, Shijiazhuang 050017, China
| | - Q Qi
- Hebei Key Laboratory of Forensic Medicine, College of Forensic Medicine, Hebei Medical University, Shijiazhuang 050017, China
| | - S J Wang
- Hebei Key Laboratory of Forensic Medicine, College of Forensic Medicine, Hebei Medical University, Shijiazhuang 050017, China
| | - C T Yang
- Hebei Key Laboratory of Forensic Medicine, College of Forensic Medicine, Hebei Medical University, Shijiazhuang 050017, China
| | - M Zuo
- Hebei Key Laboratory of Forensic Medicine, College of Forensic Medicine, Hebei Medical University, Shijiazhuang 050017, China
| | - G Z Zhang
- Hebei Key Laboratory of Forensic Medicine, College of Forensic Medicine, Hebei Medical University, Shijiazhuang 050017, China
| |
Collapse
|
9
|
Cai JL, Yan YF, Feng GW, Jing S. [Dynamic change in the gene expression profile of rat benign prostate hyperplasia tissue after complete denervation]. Zhonghua Nan Ke Xue 2019; 25:971-977. [PMID: 32233229] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
OBJECTIVE To investigate the dynamic change in the gene expression profile of the rat BPH tissue with progressive atrophy after complete denervation. METHODS Twelve 29-week-old male rats with spontaneous hypertension and spontaneously developed BPH were used for this study, of which 3 were included in the control (C) group and the other 9 underwent complete denervation of the prostate. At 3, 7 and 11 days after operation (the D3, D7 and D11 groups), all the rats were sacrificed and their ventral prostatic lobes harvested for histopathological examination and RNA extraction, and the RNA samples were subjected to whole genome microarray of the expression profile, followed by real-time RT-PCR validation and bioinformatics analysis. RESULTS Progressive atrophy of the BPH tissue was observed in the rats after complete denervation. Whole genome microarray of the expression profile was successfully performed for all the samples, and its reliability validated by real-time RT-PCR of 6 differentially expressed genes selected randomly. Hierarchical clustering analysis showed 108 up-regulated and 175 down-regulated genes in the differentially expressed ones between the D3 and C groups, 462 up-regulated and 189 down-regulated in those between the D7 and C groups, and 548 up-regulated and 256 down-regulated in those between the D11 and C groups. GO functional enrichment analysis indicated that the genes in each differentially expressed gene set participated in hundreds of molecular functions, biological processes and cellular components, while pathway enrichment analysis showed their involvement in hundreds of signaling pathways, of which many were enriched simultaneously in each differentially expressed gene set and ranked as the most enriched ones, and most of the genes involved were up-regulated and related with the activation of the complement system. CONCLUSIONS Large numbers of abnormally expressed genes are involved in the progressive atrophy of rat BPH tissue after complete denervation, and these genes participate in hundreds of molecular functions, biological progresses, cellular components and signaling pathways. Abnormal activation of the complement system may play an important role in the progressive atrophy of the BPH tissue.
Collapse
Affiliation(s)
- Jian-Liang Cai
- Department of Urology, Beijing Shijitan Hospital, Capital Medical University / Peking University Ninth School of Clinical Medicine, Beijing 100038, China
| | - Yi-Fu Yan
- Department of Urology, Beijing Shijitan Hospital, Capital Medical University / Peking University Ninth School of Clinical Medicine, Beijing 100038, China
| | - Guang-Wei Feng
- Department of Urology, Beijing Shijitan Hospital, Capital Medical University / Peking University Ninth School of Clinical Medicine, Beijing 100038, China
| | - Shuo Jing
- Department of Urology, Beijing Shijitan Hospital, Capital Medical University / Peking University Ninth School of Clinical Medicine, Beijing 100038, China
| |
Collapse
|
10
|
Hu XP, Tian Y, Zhu TY, Chen JH, Wang CX, Li XT, Xue WJ, Lin T, Peng LK, Tan JM, Feng GW, Chen ZS, Han WK, Dong J, Fan Y, Zhang XD. [Risk factors for acute rejection in living-donor kidney transplant recipients in China: a subgroup analysis of a multi-center, registry study]. Zhonghua Yi Xue Za Zhi 2017; 97:85-91. [PMID: 28088950 DOI: 10.3760/cma.j.issn.0376-2491.2017.02.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To evaluate pre-and early post-transplantation risk factors for acute rejection(AR) in kidney recipients. Methods: This subgroup analysis of a multi-center registry study was conducted on living-donor kidney transplant recipients in China with 10 years of follow-up. This study analyzed 1 255 recipients including 921 males(73.4%) and with a mean age of (33±10)years. Data from patients were first analyzed with univariate analysis and then multivariate analysis was used for finding out the potential risk factors of AR. Results: A total of 106(8.4%) patients were suspected with AR after kidney transplantation, while 1 149 patients were considered as non-AR. Multivariable analysis demonstrated a significant influence of recipient age and cold ischemia time(CIT) on the occurrence of AR(OR: 0.956, 95% CI: 0.923-0.990; OR: 1.006, 95% CI: 1.002-1.011, respectively). The frequency of severe infection was significantly higher in the AR group than non-AR group(38.7% vs 10.8%; P<0.000 1). The occurrence of new-onset diabetes mellitus and tumors was similar in the two groups. Conclusions: Recipient age and CIT are risk factors for AR after living-donor kidney transplantation. Reducing CIT and intensive management of younger recipient could benefit kidney transplant patients.
Collapse
Affiliation(s)
- X P Hu
- Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Zhang QL, Wu ZL, Xu H, Zhai B, Wang YF, Feng GW, Huang YL. A Discrete Nickel Cubane with [Ni 4
O 4
] Cluster: Synthesis, Structure, and Magnetic Property. Z Anorg Allg Chem 2016. [DOI: 10.1002/zaac.201500772] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
12
|
Zhang QL, Hu P, Zhao Y, Feng GW, Zhang YQ, Zhu BX, Tao Z. Anion-controlled assembly of silver-di(aminophenyl)sulfone coordination polymers: Syntheses, crystal structures, and solid state luminescence. J SOLID STATE CHEM 2014. [DOI: 10.1016/j.jssc.2013.11.027] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
13
|
Zhang QL, Feng GW, Zhang YQ, Zhu BX. Syntheses, structures, and luminescence properties of anion-controlled heterometal modular coordination polymers based on a metalloligand. RSC Adv 2014. [DOI: 10.1039/c3ra47303a] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
|
14
|
Jiang TL, Yan SC, Wang SF, Wu GL, Feng GW, Li LF, Li XM, Shen JH. Effect of "liuwei dihuang decoction" on prevention and treatment of tumor. J TRADIT CHIN MED 1984; 4:59-68. [PMID: 6088897] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|
15
|
Jiang TL, Feng GW, Shen JH, Li LF, Fu XQ. Observation of the effect of Spirobolus bungii extract on cancer cells. J TRADIT CHIN MED 1981; 1:34-8. [PMID: 6926686] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
|
16
|
Jiang TL, Yan SC, Wang SF, Feng GW, Li LF, Wu GL. Effect of extracts of Spirobolus bungii on transplanted tumors in mice. J TRADIT CHIN MED 1981; 1:27-33. [PMID: 6926684] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
|
17
|
Gadalla MA, Feng GW, Chiou ML. LITERATURE ABSTRACTS. Ther Drug Monit 1979. [DOI: 10.1097/00007691-197901000-00040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|